Antibodies
30 March 2007
XTL Announces the Completion of Phase I Study with XTL-6865 in Patients with Chronic Hepatitis C29 March 2007
MorphoSys and Astellas Enter Antibody Partnership – Deal Seals MorphoSys’s Third Japanese Pharmaceutical Alliance29 March 2007
Avastin Approved in Europe for First Line Treatment of Women with Metastatic Breast Cance28 March 2007
Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration28 March 2007
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech24 March 2007
MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis23 March 2007
MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies13 March 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis13 March 2007
TopoTarget Executes Its Licensing Option for the Development of Zemab for Breast Cancer8 March 2007
MAT Biopharma Announced Today the Initiation of the Phase I/II Escalating Dose of Ferritarg P(R)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports